SPT Labtech, BellBrook Labs Automate Screening for VPS4B ATPase Inhibitors for Cancer Drug Discovery
Collaborative approaches are central to SPT Labtech’s work of automating and miniaturizing complex life science workflows, according to CEO Rob Walton. “One of the key principles of our businesses is ...
To help drug developers improve the robustness of their assays, SPT Labtech and Synthace have formed a strategic collaboration that allows them to combine Design of Experiments (DoE) capabilities with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results